Interpack: Schreiner MediPharm presents innovative first-opening indication

Published: 11-Apr-2014

Flexi-Cap prevents illegal reuse with an innovative combination of label and cap and protects patients from dangerous counterfeit products

Empty medicine containers can be unnoticeably refilled and put on the market as a supposedly original product. Schreiner MediPharm will present Flexi-Cap, a first-opening indication that prevents illegal reuse with an innovative combination of label and cap, and protects patients from dangerous counterfeit products.

Flexi-Cap consists of a label combined with a capsule, similar to the cover for wine bottles, but which has been adapted to the specific requirements of the pharmaceutical industry to show clearly and irreversibly that a primary container has been opened.

First, the capsule or cap is put over the closed container, then the label is applied without covering the peel-open tab of the opening strip. Once the strip is opened, the bottom part of the cap, together with the label, remains attached to the container. Attempting to remove the rest of the cap destroys the label. This eliminates the possibility of unnoticed illegal reuse.

Flexi-Cap can be used with different container types, forms and sizes. In contrast to shrinkwrap solutions, the label construction can be applied without using heat, which makes it suitable also for temperature-sensitive medicines. The pharmaceutical manufacturer's label and brand design remain unchanged, due to the combination of label and cap.

In addition, the top of the cap allows space for bar code printing or NFC chip integration for electronic tracking. By adding extra security features, the manufacturer can further increase the hurdle for counterfeiters. In addition, the solution can be easily integrated into existing production processes.

Hall 7a, Stand D23

You may also like